Tuesday, June 30, 2026

Union Budget 2024: Know what becomes cheaper and what’s costlier

Continue reading

July 23, 2024
INDIA

New Delhi: With Finance Minister Nirmala Sitharaman announcing a major reduction in customs duty on cancer drugs and mobile phones, it is set to considerably bring down their prices in the market. The three cancer drugs are Trastuzumab deruxtecan, Osimertinib and Durvalumab.

The Finance Minister also announced a reduction of customs duty on mobile phones and mobile chargers to 15 per cent.

“The government will exempt three cancer treatment drugs from customs duty. I will also reduce basic customs duty on mobile phones, chargers and other mobile parts,” FM Sitharaman said presenting the Budget 2024.

Other products that are set to become cheaper include mobile phones, imported gold, silver, leather goods and seafood.

The reduction in duties on gold and silver by 6 per cent will significantly give a fillip to the retail demand.

FM Sitharaman also proposed a reduction in customs duties on platinum by 6.5 per cent and 5 per cent cut on seafood which includes shrimps and fish feed.

For the salaried class, the Finance Minister announced tax sops for over 4 crore salaried individuals.

Those under the new tax regime, have been given relaxation in the standard deduction limit from Rs 50,000 to Rs 75,000 while the deduction on family pension for pensioners has been enhanced from Rs 15,000 to Rs 25,000.

This will provide relief to about four crore salaried individuals and pensioners, the Finance Minister said.

(IANS)

About the Author
Sambad English Bureau

Sambad English covers latest news and happenings from Odisha from the house of Sambad Group, Eastern Media Limited.

728x90 Advertisement

You May Also Like


DISCLAIMER
All content on this website is the exclusive property of Eastern Media Limited. Any downloadable material, including but not limited to electronic or digital versions of the newspaper (e-paper) in any format, is provided solely for personal use. Unauthorized dissemination, distribution, circulation, or publication of any content or e-paper (whether in PDF or other formats) by any means, including on social media platforms, without prior authorization, permission, or license is strictly prohibited.